Literature DB >> 23016475

Prospective study of application of biological communication (cybernatics) in management of chronic low back pain--a preliminary report.

R K Ghatak1, S N Nandi, A Bhakta, G C Mandal, M Bandyopadhyay, S Kumar.   

Abstract

To observe the effects of application of cybernetics (theories of communication). This is an open level prospective study, involving patients with chronic low back pain of more than 3 months. Assessment were done before the start of therapy and after the completion of therapy every day for consecutive 6 days of treatment protocol. A total of 8 patients were enrolled (4 male, 4 female). The Visual Analogue Scale (VAS) was used to assess pain, Oswestry Disability Scale (ODI) was applied for scoring disability. ODI was scored at the start of treatment on 1st day and at the end of the treatment on 6th day. Mean VAS reduced from 8.12 to 6.93 after 1st day, which was also statistically significant (p < .01) .This trend continued and there was very significant reduction (p < .001) of VAS in the end when means were compared with pretreatment value. Mean Oswestry disability index reduced from 49.875 to 18.44 at the end of treatment which was statistically very significant (p < 0.001). There were significant improvements in all the outcome measured after Scrambler therapy.

Entities:  

Mesh:

Year:  2011        PMID: 23016475

Source DB:  PubMed          Journal:  Nepal Med Coll J


  7 in total

1.  Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial.

Authors:  Charles Loprinzi; Jennifer G Le-Rademacher; Neil Majithia; Ryan P McMurray; Carrie R O'Neill; Markus A Bendel; Andreas Beutler; Daniel H Lachance; Andrea Cheville; David M Strick; David F Black; Jon C Tilburt; Thomas J Smith
Journal:  Support Care Cancer       Date:  2019-06-17       Impact factor: 3.603

2.  A trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy.

Authors:  Patrick J Coyne; Wen Wan; Patricia Dodson; Craig Swainey; Thomas J Smith
Journal:  J Pain Palliat Care Pharmacother       Date:  2013-10-21

Review 3.  Scrambler Therapy for the management of chronic pain.

Authors:  Neil Majithia; Thomas J Smith; Patrick J Coyne; Salahadin Abdi; Deirdre R Pachman; Daniel Lachance; Randy Shelerud; Andrea Cheville; Jeffrey R Basford; David Farley; Carrie O'Neill; Kathryn J Ruddy; Frank Sparadeo; Andreas Beutler; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2016-04-04       Impact factor: 3.603

4.  Use of Scrambler Therapy in Acute Paediatric Pain: A Case Report and Review of the Literature.

Authors:  Sabrina Congedi; Silvia Spadini; Chiara Di Pede; Martina Ometto; Tatiana Franceschi; Valentina De Tommasi; Caterina Agosto; Pierina Lazzarin; Franca Benini
Journal:  Case Rep Pediatr       Date:  2016-02-08

5.  Impact of Scrambler Therapy on Pain Management and Quality of Life in Cancer Patients: A Study of Twenty Cases.

Authors:  Komal Kashyap; Saurabh Joshi; Saurabh Vig; Vishwajeet Singh; Sushma Bhatnagar
Journal:  Indian J Palliat Care       Date:  2017 Jan-Mar

Review 6.  Inside the Scrambler Therapy, a Noninvasive Treatment of Chronic Neuropathic and Cancer Pain: From the Gate Control Theory to the Active Principle of Information.

Authors:  Giuseppe Marineo
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

7.  Scrambler therapy: what's new after 15 years? The results from 219 patients treated for chronic pain.

Authors:  Marianna Ricci; Laura Fabbri; Sara Pirotti; Nicola Ruffilli; Flavia Foca; Marco Maltoni
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.